Organization: Health Canada
Year: 2020
Month: August
Request Number: A-2020-000015
Request Summary: Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on PatentedMedicines (Notice of Compliance) Regulations.
Disposition: All disclosed
Number of pages: 1